Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Issue of Equity

26 Jan 2012 07:00

RNS Number : 2000W
Quindell Portfolio PLC
26 January 2012
 



26 January 2012

 

Quindell Portfolio Plc

("Quindell" or the "Company")

 

Issue of Equity

 

Quindell Portfolio Plc (AIM: QPP.L), the brand extension company and a leading practice provider of consultancy, software and outsourcing in its key markets, announces that on 25 January 2012, pursuant to the announcement made by the Group on 29 December 2011 in relation to the Group's recommended share offer for Mobile Doctors Group Plc, the Board of Quindell has issued and allotted a further 2,975,649 new Quindell shares of 1 pence each ("New Shares").

 

Application has been made for the 2,975,649 New Shares to be admitted to trading on AIM. Admission of the shares is expected to occur on 31 January 2012. Following Admission Quindell will have 2,065,402,088 ordinary shares in issue. The Company has no ordinary shares held in treasury. The total of 2,065,402,088 ordinary shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

For further information:

Quindell Portfolio PlcRob Terry, Chairman & Chief Executive

 

Laurence Moorse, Group Finance Director

Tel: 01329 830 501

terryr@quindell.com

Tel: 01329 830 543

moorsel@quindell.com

Daniel Stewart & Company Plc(Nominated Adviser & Joint broker)Antony Legge/James Thomas

 

Tel: 020 7776 6566

 

Cenkos Securities plc (Joint broker) Stephen Keys /Adrian Hargrave / Alex Aylen / Andy Roberts 

 

 

Tel: 020 7397 8900

 

Media EnquiriesRedleafPolhill Limited

Rebecca Sanders-Hewett

Jenny Bahr

 

Quindell Portfolio PlcTracey Terry, Chief Communications Officer

 

 

Tel: 020 7566 6720

quindell@redleafpolhill.com

 

 

Tel: 01329 830 501

terrylt@quindell.com

 

Notes to Editors:

 

About Quindell Portfolio Plc

Quindell, the Brand Extension Company, helps its clients and partners to utilise their brands enabling them to achieve greater sales, provide better service and extend the brand into new product offerings and alternative routes to market.

 

The Group works with over 2,000 brands from SMEs to blue-chips around the globe, with solutions applying to the following Sectors & related Supply Chains:

 

·; Telecoms, Utilities, Retail & E-commerce

·; Finance, Insurance, Health & Legal

·; Government & Public Sector

 

Quindell Portfolio joined the market through Mission Capital Plc. The Group was readmitted to the market on 17 May 2011 following the acquisition of Quindell Limited. On 18 July 2011, the Company was renamed Quindell Portfolio Plc. In December 2011, Mobile Doctors Group Plc was acquired increasing run-rate revenue to over £50 million and staff levels to over 600 including our off-shore capability.

 

 

Our Solutions

In addition to extending our clients' brands, Quindell's solutions are focused on generating improvements in efficiency and effectiveness in sales and service transactions with savings of over 20% against industry norms achieved.

 

Our Consultancy drives the business transformation for our clients, and is supported by leading edge technology, outsourcing, membership schemes and social media via repeatable solutions.

 

Our Software provides cloud based industry solutions to deliver the necessary framework to meet online, office and field based sales and service expectations of our clients and their customers.

 

Our "Sales" Technology Enabled Outsourcing leverages our own Business & Home Advisory Service brands to provide a White Labelled proposition for partners to extend into offerings for Telecoms, Utilities, Finance, Insurance, Health and Legal Services.

 

Our "Service" Technology Enabled Outsourcing covers a broad range of solutions and in insurance, already recognised as a market leader for independent medical evidence via a panel of circa 2,500 medical experts providing circa 11% of reports for UK Personal Injury claims.

 

For further information, please visit www.quindell.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESELEFIFESEDF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.